The dvm360® equine medicine page is a comprehensive resource for clinical news and insights on the latest in veterinary equine medicine. This page consists of videos, interviews, articles, podcasts, and research on the advancements and developments of therapies for equine medicine, and more.
April 3rd 2025
This skeletal muscle infection is best managed in a hospital
AAEP summer session to cover foot disorders, practice management
April 12th 2009Columbus, Ohio -- Veterinarians attending the American Association of Equine Practitioners' continuing-education meeting this summer will get two-for-one instructional sessions -- one focusing on diagnosis and treatment of equine foot disorders and the other on how to build a practice that can survive the recession.
CEM outbreak source remains elusive despite painstaking search
April 8th 2009National Report -- With a nationwide outbreak of contagious equine metritis (CEM) now nearly four months old, state and federal investigators say they still can't draw any conclusions regarding the source of the treatable reproductive disease.
Newest strides in treating acute laminitis (Proceedings)
April 1st 2009Laminitis is frustrating for veterinarians because current knowledge and understanding of the pathophysiology and progression of the disease are incomplete, limiting efforts to prevent and treat this devastating disease successfully.
From hematuria to perineal scalding: Urinary tract disorders (Proceedings)
April 1st 2009Urinary tract disorders occur infrequently in horses but represent significant diagnostic and therapeutic challenges. In this article, we will discuss identification and management of urinary incontinence and bladder dysfunction, urolithiasis, and hematuria.
Evaluating treatment choices for tendon, ligament injury and joint disease in the horse
April 1st 2009In the first of these articles we looked at the wide array of different treatment modalities and therapies available for use in horses suffering from varying types of tendon and ligament injuries, and forms of joint disease. Multiple treatment options are available, from stem cells to platelet-rich plasma to shock-wave therapy to Tildren.